Middle East & Africa Gene Therapy Market to 2032

Overview

The Middle East & Africa Gene Therapy Market is expected to reach a 1,386.10 USD Billion by 2032 and is projected to grow at a CAGR of 24.52% from 2025 to 2032.

Revenue, 2024 (USD Billion)

404.26

Forecast, 2032 (USD Billion)

1,386.10

CAGR, 2024 - 2032

24.52%

Report Coverage

Middle East & Africa

Middle East & Africa Gene Therapy Market 2018-2032 USD Billion

Middle East & Africa Gene Therapy Market, Key Findings (2025-2032)

Market Growth and Projections:

Market Size (2024): 404.26 USD Billion
Projected Market Size (2032): 1,386.10 USD Billion
CAGR (2025-2032): 24.52%

Key Findings of Middle East & Africa Gene Therapy Market

The Middle East & Africa Gene Therapy Market was valued at 404.26 USD Billion in 2024.
The Middle East & Africa Gene Therapy Market is likely to grow at a CAGR of 24.52% during the forecast period of 2024 to 2032.
In 2024, the Largest segment Viral Vector in Vector Segment accounted for the largest share of the market with a revenue of 317.11 USD Billion
The fastest growing segment Oncological Disorders in Application Segment grew Fastest with a CAGR of 27.28% during the forecast period from 2024 to 2032.

Middle East & Africa Gene Therapy Market Scope

Middle East & Africa Gene Therapy Market Segmentation & Scope

Application

Other Diseases
Neurological Disorders
Rare Diseases
Cardiovascular Diseases
Infectious Disease
Oncological Disorders

Method

In-Vivo
Ex-Vivo

Vector

Non-Viral Vector
Viral Vector

End User

Others
Research Institutes
Hospitals
Cancer Institutes

Middle East & Africa Gene Therapy Market Data Coverage Insights

Study Period	2024-2032
Base Year	2021
Unit	Revenue in USD Billion
Market Value in 2024	404.26 USD Billion
Market Value in 2032	1,386.10 USD Billion
CAGR (2025-2032)	24.52%
Historic Data	2016-2023
Market Segments Covered	Application,Method,Vector,End User

Regional Insights:

Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 404.26 USD Billion in 2024
- Key Country: South Africa, leading in terms of revenue with value of 360.94 USD Billion in 2024.

Segments and Scope

Middle East & Africa Gene Therapy Market to 2032, By Application
- Oncological Disorders is the largest segment in Middle East & Africa Gene Therapy Market to 2032 with a revenue of 194.89 USD Billion in the year 2024.
- Oncological Disorders is the Fastest growing segment in Middle East & Africa Gene Therapy Market to 2032 with a Growth rate of 27.28 % in forecast period 2025-2032.
Middle East & Africa Gene Therapy Market to 2032, By Method
- Ex-Vivo is the largest segment in Middle East & Africa Gene Therapy Market to 2032 with a revenue of 309.99 USD Billion in the year 2024.
- Ex-Vivo is the Fastest growing segment in Middle East & Africa Gene Therapy Market to 2032 with a Growth rate of 25.63 % in forecast period 2025-2032.
Middle East & Africa Gene Therapy Market to 2032, By Vector
- Viral Vector is the largest segment in Middle East & Africa Gene Therapy Market to 2032 with a revenue of 317.11 USD Billion in the year 2024.
- Viral Vector is the Fastest growing segment in Middle East & Africa Gene Therapy Market to 2032 with a Growth rate of 25.66 % in forecast period 2025-2032.
Middle East & Africa Gene Therapy Market to 2032, By End User
- Cancer Institutes is the largest segment in Middle East & Africa Gene Therapy Market to 2032 with a revenue of 183.60 USD Billion in the year 2024.
- Cancer Institutes is the Fastest growing segment in Middle East & Africa Gene Therapy Market to 2032 with a Growth rate of 26.16 % in forecast period 2025-2032.

Middle East & Africa Gene Therapy Market Company Share Analysis

Company Name
Oxford Biomedica
Novartis AG
Kite Pharma Inc.
Biogen
Bristol-Myers Squibb Company

Middle East & Africa Gene Therapy Market Geographical Sales Distribution, 2018-2032 USD Billion

Middle East & Africa Gene Therapy Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market

Middle East & Africa Cold Sore Treatment Market

North America Cold Sore Treatment Market

Europe Cold Sore Treatment Market

Asia-Pacific Cold Sore Treatment Market

Argentina Cold Sore Treatment Market

Australia Cold Sore Treatment Market

Austria Cold Sore Treatment Market

Belgium Cold Sore Treatment Market

Brazil Cold Sore Treatment Market

Frequently Asked Questions

What are the primary segments covered in the Middle East & Africa Gene Therapy Market?

The Middle East & Africa Gene Therapy Market is segmented based on Segmentation Application,Method,Vector,End User.

What is the current market size of the Middle East & Africa Gene Therapy Market?

Middle East & Africa Gene Therapy Market was valued at USD 404.26(Revenue in USD Billion) in 2021.

What is the expected growth rate of the Middle East & Africa Gene Therapy Market?

Middle East & Africa Gene Therapy Market is projected to grow at a CAGR of 24.52% during the forecast period of 2024 to 2032.

Which is the dominating segment in the Middle East & Africa Gene Therapy Market?

The Viral Vector segment is expected to dominate the Middle East & Africa Gene Therapy Market, holding a largest market share of 317.11 USD Billion in 2024